On October 28, 2022, Impactive Capital LP announced that as of October 24, 2022, it has ceased to beneficially own more than 5% of the outstanding shares of Meridian Bioscience, Inc. Hence, the campaign is deemed to be withdrawn.
Meridian Bioscience, Inc.
Equities
VIVO
US5895841014
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-5.81% | 18TCr | |
-1.63% | 11TCr | |
-4.14% | 6.75TCr | |
-6.56% | 4.61TCr | |
+13.22% | 4.58TCr | |
+6.13% | 4.16TCr | |
+19.93% | 3.11TCr | |
+13.61% | 2.48TCr | |
-5.36% | 2.43TCr |